- Talaris Therapeutics press release (NASDAQ:TALS): Q1 GAAP EPS of -$0.45.
- $225.5 million in cash, cash equivalents and marketable securities compared with $140.1 million as of March 31, 2021.
Talaris Therapeutics GAAP EPS of -$0.45
Recommended For You
More Trending News
About TRML Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
TRML | - | - |
Tourmaline Bio, Inc. |